6ix — Find Your Next Investment

Discover investor relations events, company profiles, and investment opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

About

Molecular Partners Ag (SW:MOLN) — investor relations, events, news, and company updates on 6ix.

Latest News

Molecular Partners presents three posters at AACR 2026, with new preclinical data for first Switch-DARPin T cell engager MP0632 and DLL3 Radio-DARPin MP0712

Molecular Partners Announces Presentation of First Imaging and Dosimetry Data of DLL3-Targeting Radiotherapy MP0712 in Patients at TWC 2026

Molecular Partners Highlights Clinical Development Progress and Anticipated Milestones at 44th Annual J.P. Morgan Healthcare Conference

Molecular Partners to Present at 44th Annual J.P. Morgan Healthcare Conference

Molecular Partners Forms Scientific Advisory Board to Accelerate Development of Targeted Radiotherapeutics

Recent Videos

My biggest takeaway from Molecular Partners' 2025 Report

My biggest takeaway from Molecular Partners' 2025 Report

Mar 17, 2026

DISCOVER how Molecular Partners uses the Triceratops SPR#64 for kinetic screenings

DISCOVER how Molecular Partners uses the Triceratops SPR#64 for kinetic screenings

Feb 26, 2026

Molecular Partners First Imaging and Dosimetry Data of DLL3 Targeting Radiotherapy MP0712 | Feb 02

Molecular Partners First Imaging and Dosimetry Data of DLL3 Targeting Radiotherapy MP0712 | Feb 02

Feb 03, 2026

Molecular Partners AG (MOLN) #investmentthesis #penetratingdensetumortissue #engagingmultipletargets

Molecular Partners AG (MOLN) #investmentthesis #penetratingdensetumortissue #engagingmultipletargets

Dec 09, 2025

Community Chat

Ask AI